WGSHealthcareSmall-Cap
GeneDx Holdings Corp. Insider Trading Activity
Every SEC Form 4 insider transaction reported for GeneDx Holdings Corp. (WGS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are WGS insiders buying or selling?
GeneDx Holdings Corp. insiders reported 26 open-market buys ($305.8M) and 201 sells ($239.5M) across 227 Form 4 filings — a net buying position of $66.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 18, 2026)
Total Form 4 filings
227
SEC EDGAR
Insider filers
22
Insider buys (26)
$305.8M
Insider sells (201)
$239.5M
Insider sentiment
Net buyingNet insider flow of $66.3M in net buying. 4 insider buys in the last 90 days.
Recent WGS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 3.7K | $60.77 | $226.6K |
| Jun 18, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 10.5K | $60.77 | $638.1K |
| Jun 11, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 1.3K | $53.77 | $68.1K |
| Jun 11, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 3.6K | $53.77 | $195.7K |
| Jun 8, 2026 | Eli Casdin | Director, 10% Owner | Purchase | 200.0K | $55.55 | $11.1M |
| Jun 3, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 369 | $51.74 | $19.1K |
| May 20, 2026 | Eli Casdin | Director, 10% Owner | Purchase | 500.0K | $42.92 | $21.5M |
| May 15, 2026 | Keith A. Meister | Director, 10% Owner | Purchase | 351.3K | $39.19 | $13.8M |
| May 12, 2026 | Keith A. Meister | Director, 10% Owner | Purchase | 1.2M | $38.84 | $46.8M |
| May 1, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 2.2K | $65.19 | $141.6K |
| May 1, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 392 | $65.19 | $25.6K |
| Mar 30, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 8.8K | $63.17 | $557.1K |
| Mar 30, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 46.9K | $63.17 | $3.0M |
| Mar 17, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 17.2K | $76.80 | $1.3M |
| Mar 17, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 5.7K | $76.80 | $438.2K |
| Mar 11, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 1.3K | $86.75 | $111.0K |
| Mar 11, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 3.7K | $86.75 | $319.1K |
| Mar 6, 2026 | Keith A. Meister | Director, 10% Owner | Purchase | 169.5K | $79.40 | $13.5M |
| Mar 5, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 6.2K | $78.61 | $486.4K |
| Mar 5, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 25.5K | $78.61 | $2.0M |
| Mar 3, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 287 | $77.52 | $22.2K |
| Feb 6, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 6.0K | $85.70 | $510.9K |
| Feb 4, 2026 | Bryan Dechairo | Chief Operating Officer | Sale | 3.4K | $99.53 | $339.7K |
| Feb 2, 2026 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale | 317 | $93.99 | $29.8K |
| Feb 2, 2026 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sale | 1.7K | $94.00 | $155.4K |
Showing the 25 most recent of 227 Form 4 filings for GeneDx Holdings Corp..
Most active WGS insiders
- Kevin Feeley63 filings
- Katherine Stueland48 filings
- Kareem Saad26 filings
- Karen Ann White15 filings
- OPKO HEALTH, INC.11 filings
Ask anything about WGS insider activity
Use Trabud's AI agent to query GeneDx Holdings Corp.'s Form 4 history in plain English — "Show me WGS CEO purchases this year" or compare it against any other ticker.
Open the AI agentWGS insider trading FAQ
Are GeneDx Holdings Corp. insiders buying or selling?
Across 227 SEC Form 4 filings, GeneDx Holdings Corp. (WGS) insiders reported 26 open-market purchases totaling $305.8M and 201 sales totaling $239.5M. That is a net buying position of $66.3M.
How many insiders trade WGS stock?
22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GeneDx Holdings Corp.. The most recent filing was accepted on Jun 18, 2026.
Where does Trabud get WGS insider trading data?
All WGS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.